breast cancer profile

breast cancer profile

(1) A battery of tests performed on a serum sample to screen for breast cancer—e.g., BRCA1, BRCA2, urine CEA, CA 15-3. This particular profile is not widely used to screen for breast cancer as it has a relatively low diagnostic yield.
(2) A proprietary battery (Symphony suite) of assays performed on paraffin-embedded tissue to provide a decision support system for managing breast cancer.

Symphony suite
MammaPrint—Determines risk of recurrence.
BluePrint—Determines molecular subtypes.
TargetPrint—Determines ER, PR and HER2 status.
TheraPrint—Identifies alternative types of therapy for metastatic disease.
Mentioned in ?
References in periodicals archive ?
The Insight Dx Breast Cancer Profile helps physicians identify the probability of a patient's cancer recurring and assess the need for chemotherapy.
Nasdaq:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, announced today that new data will be presented during the San Antonio Breast Cancer Symposium, validating Clarient's new prognostic breast cancer profile - Clarient Insight(TM) Dx.
We are very excited that these published results validate our Clarient Insight Dx Breast Cancer Profile," said Ron Andrews, Clarient's Chief Executive Officer.

Full browser ?